Rere Adrea Novattra
FDA import alert and refusal historyPontianak, IndonesiaFEI 3011466674
As of October 27, 2026, Rere Adrea Novattra (Pontianak, Indonesia) is on the red list of FDA Import Alert 54-15 (Supplements and ingredients containing kratom) for mitragyna speciosa (kratom); kratom (herbal and botanical teas ii, continued); kratom (herbal and botanicals, not teas ii), published by FDA on September 23, 2015, and has no FDA import refusals recorded since October 2016.
Data from FDA public records, last checked . Request a correction
Current status
- Import alerts
- IA 54-15 · red list
- Last import refusal
- None since October 2016
- Last warning letter
- None found
- Last inspection
- None on record
Every FDA record for Rere Adrea Novattra
1 record, newest first. Each line links to the FDA page it came from.
2015
- Import alert listingListed on Import Alert 54-15red listMitragyna Speciosa (Kratom); Kratom (Herbal and Botanical Teas II, continued); Kratom (Herbal and Botanicals, not Teas II)Source
Questions about Rere Adrea Novattra
- Is Rere Adrea Novattra on an FDA import alert?
- Yes. As of October 27, 2026, Rere Adrea Novattra is on the red list of FDA Import Alert 54-15, “Supplements and ingredients containing kratom”, for mitragyna speciosa (kratom); kratom (herbal and botanical teas ii, continued); kratom (herbal and botanicals, not teas ii); FDA published the listing on September 23, 2015.
- Has FDA refused shipments from Rere Adrea Novattra?
- No FDA import refusals for Rere Adrea Novattra appear in FDA's refusal data since October 2016, as of October 27, 2026.
- What is Rere Adrea Novattra's FEI number?
- Rere Adrea Novattra's FDA Establishment Identifier (FEI) is 3011466674.
- Can shipments from Rere Adrea Novattra still enter the U.S.?
- Shipments of mitragyna speciosa (kratom); kratom (herbal and botanical teas ii, continued); kratom (herbal and botanicals, not teas ii) from Rere Adrea Novattra can be detained without physical examination under Import Alert 54-15; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).
Buying from Rere Adrea Novattra?
Watch it and get the FDA record the day it changes. Free for one supplier.
SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.